Related Experiment Videos
Soft tissue and bone sarcomas in association with pregnancy
1Department of Medicine, Institut Gustave Roussy, Villejuif, France.
Acta Oncologica (Stockholm, Sweden)
|March 2, 1999
Summary
Pregnancy and sarcoma diagnosis present unique challenges, often leading to delayed treatment due to various factors. However, diagnostic tests and some treatments appear safe for both mother and fetus during gestation.
Area of Science:
- Oncology
- Obstetrics & Gynecology
- Radiology
Background:
- Sarcomas during pregnancy are rare, with unclear effects of pregnancy on tumor development.
- Managing cancer in pregnant patients involves balancing maternal treatment with fetal well-being.
- This study reviews cases of sarcoma diagnosed during or shortly after pregnancy.
Purpose of the Study:
- To investigate the challenges and outcomes of diagnosing and treating sarcomas in pregnant women.
- To assess the safety and efficacy of diagnostic modalities and treatments during gestation.
- To highlight the complex medical, ethical, and emotional considerations involved.
Main Methods:
- Retrospective review of medical files for seven pregnant women with sarcoma.
- Analysis of tumor types (bone vs. soft tissue), diagnostic delays, and treatment approaches.
- Evaluation of diagnostic test safety (MRI, ultrasound) and chemotherapy toxicity.
Main Results:
- Five out of seven cases experienced delayed diagnosis and treatment for various reasons.
- Diagnostic imaging (MRI, ultrasound) and biopsy were deemed safe during pregnancy.
- Limited chemotherapy (Adriamycin, ifosfamide, granisetron) in the third trimester showed no significant fetal toxicity.
Conclusions:
- Diagnosing and treating sarcoma in pregnancy requires careful consideration of maternal and fetal risks.
- Early diagnostic tests and appropriate treatments can be safely implemented.
- Addressing the multifaceted dilemmas is crucial for optimal patient care.